Article
Molecular features, markers, drug targets, and prospective targeted therapeutics in cardiac myxoma.
Current cancer drug targets - 1 Sept 2009
Barh Debmalya, Kumar Anil, Chatterjee Suvro, Liloglou Triantafillos
Abstract excerpt
Treatment of sporadic cardiac myxoma (CM) has always been a challenging task. Currently, surgical excision remains the only option; however, targeted drug discovery schemes are in progress in order to improve treatment strategies and efficacy. The molecular mechanisms behind CM pathogenesis are still not totally unveiled thus drug target identification is still at early steps, trying to compile structured data on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.